Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.5.2.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.45NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GP.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.4.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.62NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.80 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.43.8 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.128 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.21NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.220NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.58NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.438NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.257NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.5.4 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.323NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.15NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.105 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.4 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.9 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.398NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.94 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HK.18NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.18NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.17NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.164NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.275NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.58NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.81NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.419NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.151NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.19NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.311NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.93NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.104NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.225NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.2.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AV.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-14372.8South Korea
B.1.1.309NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.105NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.307NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.171NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used